Skip to main content
Equibles
TNYA logo

TNYA · Tenaya Therapeutics, Inc. · Metrics

Track TNYA — free

Use TNYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TNYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.42 +0.04 (+10.62%)
Rebalance outlook locked
Market Cap
$84.67M
Shares
224.23M
Volume · Oct 20 2.75M Avg daily vol (3M) 2.67M

TNYA metrics

72 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.38
Market cap
$84.67M

Price action

20 metrics
Price change (1W)
-33.2%
Price change (30D)
-44.0%
Price change (3M)
-53.8%
Price change (6M)
-49.0%
Price change (YTD)
-47.0%
Price change (1Y)
-79.1%
Trailing year
Price change (5Y)
-98.1%
52-week high
$1.97
52-week low
$0.38
Change from 52-week high
-80.8%
Change from 52-week low
+0.0%
Annualized volatility
100.7%
Annualized volatility (3M)
68.9%
Beta
2.7
RSI (14D)
21.8
Price vs SMA 50
-40.4%
Price vs SMA 200
-48.0%
Avg volume (3M)
2.67M
Relative volume
1.1
Average dollar volume
$1.63M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
224.23M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.2
reciprocal yield 81.3%
FCF yield
-61.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-120.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-06-03

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$105.86M
Net income (TTM)
−$103.11M
Trailing 12 months
Diluted EPS (TTM)
$-0.50
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.54
EBITDA per diluted share (TTM)
$-0.50
Net income per diluted share (TTM)
$-0.53
Operating cash flow per diluted share (TTM)
$-0.28
Free cash flow per diluted share (TTM)
$-0.28
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.32
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$0.57

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+33.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-148.6%
Return on assets
-110.2%
Debt / equity
0.0
Current ratio
4.5
EBITDA (TTM)
−$98.73M
Free cash flow (TTM)
−$52.59M
Quick ratio
4.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$78.08M
Latest balance sheet
Cash & equivalents
$78.08M
Total assets
$93.54M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$52.33M
Capital expenditures (TTM)
$263,000
R&D (TTM)
$61.61M
SG&A (TTM)
—
Stock compensation (TTM)
$9.58M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
101
13F filer change QoQ
-2
Institutional ownership
24.1%
Conviction holders (share of 13F filers)
2.0%
Crowding (high-turnover and private-fund holders)
15.1%
Private-fund adviser ownership
14.6%
Active holders' share change QoQ
+0.4%
Holder tenure
7.5
Price vs estimated holder cost
-70.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.6%

Short interest

3 metrics
Short interest
10.2%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$21,048
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1858848 CUSIP 87990A106 13F (30d) 6 filings 6 filers Visit website Investor relations